Stocktoria
FEMASYS INC FEMY
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-06-18
FEMASYS INC financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.3M | $1.6M | $1.1M | $1.2M | $1.2M | $1.0M |
| Gross profit | — | — | — | $764,280 | $809,305 | $731,385 |
| R&D expense | $7.6M | $8.2M | $7.2M | $5.8M | $4.1M | $4.1M |
| Operating income | -$17.6M | -$17.8M | -$14.5M | -$11.6M | -$8.3M | -$6.9M |
| Interest expense | — | — | $165,390 | $13,464 | $19,226 | $12,553 |
| Income tax | $1,297 | $9,602 | $4,338 | $6,300 | $4,000 | $1,800 |
| Net income | -$18.6M | -$18.8M | -$14.2M | -$11.4M | -$7.5M | -$6.9M |
| EPS (diluted) | $-0.47 | $-0.85 | $-0.93 | $-0.96 | $-1.12 | $-7.20 |
| Operating cash flow | -$18.7M | -$19.4M | -$11.3M | -$10.7M | -$7.9M | -$4.9M |
| Free cash flow | -$19.2M | -$20.2M | -$11.4M | -$11.1M | -$8.2M | -$4.9M |
| Cash & equivalents | $9.3M | $3.5M | $21.7M | $13.0M | $24.8M | $3.3M |
| Inventory | $5.7M | $3.0M | $667,118 | $436,723 | $208,270 | $131,378 |
| Total assets | $20.7M | $12.4M | $27.8M | $16.9M | $28.6M | $7.6M |
| Total liabilities | $14.9M | $10.1M | $9.4M | $1.7M | $2.2M | $4.1M |
| Shareholders' equity | $5.9M | $2.3M | $18.4M | $15.2M | $26.3M | -$51.8M |
Growth · year-over-year · Revenue CAGR 17.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +40.8% | +52.0% | -11.1% | +2.2% | +13.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.